[1] Xue T,Roy R.Studying traditional Chinese medicine[J].Science,2003,300(5620):740-741.
[2] State Council of the PRC.Drug Administrative Law[Z].Beijing,China,1985.
[3] Ministry of Health of the PRC.Provisions for New Drug Approval[Z].Beijing,China,1985.
[4] Deng RL,Kaitin K.The regulation and approval of new drugs in China[J].Drug Info,2004,(37):29-39.
[5] SFDA.Provisions for Drug Registration[Z].(No.2).Beijing,China,1999.
[6] Fan TP,Deal G,Koo HL,et al.Future development of global regulations of Chinese herbal products[J].J Ethnopharmacol,2012,140(3):568-586.
[7] SFDA.Provisions for Drug Registration[Z].(No.28).Beijing,China,2007.
[8] Miller LH SX.Artemisinin:discovery from the Chinese herbal garden[J].Cell,2011,146(6):855-859.
[9] Pharmacopoeia of the People's Republic of China English edition(2010)[S].Vol.I.2010:1884.
[10] Liu JM,Ni MY,Fan JF,et al.Artemisinin structures and reactions[J].Acta Chim Sin,1979,37:129-143.
[11] Lin AJ,Klayman DL,Milhous WK.Antimalarial activity of new water-soluble dihydroartemisinin derivatives[J].J Med Chem,1987,30(11):2147-2150.
[12] Deng RX.New progress in studies on antimalarial drugs in recent years in China[J].Chinese J Pharm,1989,20(8):372-375.
[13] Bai DL.Traditional Chinese medicines and new drug development[J].Pure Appl Chem,1993,65(6):1103-1112.
[14] Sun HD ML,Hu X C,et al.Ai-Ling I treated 32 cases of acute promyelocytic leukemia[J].Chin J Integr Tradit West Med,1992,12(3):170-171.
[15] Chen GQ,Zhu J,Shi XG,et al.In vitro studies on cellular and molecular mechanisms of arsenic trioxide(As2O3) in the treatment of acute promyelocytic leukemia:As2O3 induces NB4 cell apoptosis with downregulation of Bcl-2 expression and modulation of PML-RAR alpha/PML proteins[J].Blood,1996,88(3):1052-1061.
[16] Mervis J.Ancient remedy performs new tricks[J].Science,1996,273(2):578.
[17] Liu G.From Schisandra research to the discovery of benzene diester[J].Acta Chim Sin,1983,18(9):714-720.
[18] Anufriev VP,Malinovskaya GV,Denisenko VA,et al.Synthesis of ginsenoside Rg3,a minor constituent of Ginseng radix[J].Carbohydr Res,1997,304(2):179-182.
[19] SunY,Lin H,Zhu YZ,et al.A randomized,prospective,multi-centre clinical trial of NP regimen(vinorelbine+cisplatin) plus Gensing Rg3 in the treatment of advanced non-small cell lung cancer patients[J].Chin J Lung Cancer,2006,9(3):254-258.
[20] Liu J,Sun L,Zhao Y,et al.Clinical phase II study on immu noimprovement of patients with breast cancer treated by shenyi capsule[J].Chin J Clin Oncol,2000,27(7):534-536.
[21] Sucher NJ.The application of Chinese medicine to novel drug discovery[J].Expert Opin Drug Discov,2013,8(1):21-34.
[22] Guo LY,Li CY.Cordyceps kyushuensis new to China[J].Mycosystema,2000,19(02):296.
[23] Li A.Establishment of Quality Standard and Fingerprint Chromatograph of Ipomoea batatas(L.) Lam.Simon No.1[D].Central South University.2010.
[24] Ju FX.Pharmaceutical Research of Capsule of Mangjishi[D].Jilin University.2012.
[25] Chen ZA,Liu GY,Hu SY.Studies on cultivation of Paecilomyces cicadae and its pharmacological function[J].Acta Mycologica Sin,1993,12(2):138-144.
[26] Liu CJ.Niu R.Method for preparing confervoide oil and medicine containing thereof[P].Chinese patent CN200310104187 Year Needed.
[27] Zhao CF,Liu JP,Li PY.Studies on the Fructus Panax Quinquefolii for medicinal use[J].Lishenzhen Med Mater Med Res,2007,18(1):115-116.
[28] Liu JZ,Li GY,Zhang B,et al.The effect of haishengsu on Lewis lung cancer[J].Shandong Med J,2009,49(07):30-31.
[29] Zhou YH.Analysis on application for registration of active fractions in Chinese materia medica during 2004-2007[J].Chin Tradit Herb Drugs,2009,40(8):1177-1181.
[30] SFDA.Supplement of Provision for Traditional Chinese Medicine Registration[Z].Beijing,China,2008.